RESUMEN
Data coming from the literature investigating the effectiveness and interaction between smoking cessation (SC) and lung cancer screening (LCScr) are still sparse and inconsistent. Herein, we report the preliminary results from the ongoing lung cancer screening trial ("Cosmos-II") focusing our analysis on the inter-relationship between the SC program and the LCScr.
Asunto(s)
Detección Precoz del Cáncer/métodos , Neoplasias Pulmonares/diagnóstico , Cese del Hábito de Fumar , Prevención del Hábito de Fumar , Anciano , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Neoplasias Pulmonares/etiología , Masculino , Persona de Mediana Edad , Motivación , Cooperación del Paciente , Evaluación de Programas y Proyectos de Salud , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Ciudad de Roma , Fumar/efectos adversos , Fumar/psicología , Cese del Hábito de Fumar/psicología , Factores de TiempoRESUMEN
Primary pulmonary extra-nodal MALT-lymphomas are very uncommon. Clinical-radiological pattern is variable and usually non-specific and a correct diagnosis usually requires the histopathological examination. Herein we report a case of a 59-year-old man presented with dyspnea at the slightest effort and dry cough. At imaging multiple pulmonary consolidations with interlobular septal thickenings and ground-glass opacities were disclosed, defining a crazy paving pattern. The surgical approach was necessary to reach the diagnosis of primary pulmonary low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma). Immunotherapy (Rituximab) and chemotherapy (Bendamustine) were started leading to a progressive improvement of the disease. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 260-263).